CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, CYP2E1, which plays a key role in the generation of oxidative stress in NAFLD, activate HSCs, and increase the secretion of type I collagen; moreover, anti-oxidants and CYP2E1 inhibitors could block these effects (Urtasun et al., 2008).